Laifer S A, Kuller J A, Hill L M
Department of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pennsylvania.
Obstet Gynecol. 1990 Oct;76(4):723-4.
Successful treatment of severe fetal hemolytic disease depends on rapid and accurate measurement of fetal hemoglobin or hematocrit. The HemoCue is a portable hemoglobinometer that rapidly measures hemoglobin concentration. To evaluate the potential role of this instrument in fetal transfusion therapy, we measured hemoglobin concentration with the HemoCue and compared it with Coulter counter determination of hemoglobin in 39 fetuses. The HemoCue accurately measured fetal hemoglobin concentration (y = -0.3986 + 1.0276x; r = 0.97, P less than .001). This instrument is valuable for use with intravascular fetal transfusions.
严重胎儿溶血病的成功治疗取决于对胎儿血红蛋白或血细胞比容的快速准确测量。HemoCue是一种可快速测量血红蛋白浓度的便携式血红蛋白仪。为评估该仪器在胎儿输血治疗中的潜在作用，我们用HemoCue测量了39例胎儿的血红蛋白浓度，并将其与用库尔特计数器测定的血红蛋白浓度进行比较。HemoCue能准确测量胎儿血红蛋白浓度（y = -0.3986 + 1.0276x；r = 0.97，P <.001）。该仪器在胎儿血管内输血中很有价值。
